-
A Drive for Diversity
African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Living Beyond a Diagnosis
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
-
Cancer and COVID-19 Vaccination
Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Colorectal Cancer Screenings at Home
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
Roadblocks to Care
Some cancer patients struggle to find transportation to their appointments. The coronavirus pandemic has further limited options for patients looking for rides.
by Anna Goshua
-
Get Involved
Smiling FacesRich Nardiello seeks to bring a smile to children with cancer.
by Bradley Jones
-
Q&A
Ethics in PracticeRebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
by Marci A. Landsmann
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff